Search Results - "Upadhyay, Vivek A."

Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark by Taylor, Justin, Haddadin, Michael, Upadhyay, Vivek A., Grussie, Erwin, Mehta-Shah, Neha, Brunner, Andrew M., Louissaint, Abner, Lovitch, Scott B., Dogan, Ahmet, Fathi, Amir T., Stone, Richard M., Tallman, Martin S., Rampal, Raajit K., Neuberg, Donna S., Stevenson, Kristen E., Horwitz, Steven M., Lane, Andrew A.

“…Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an uncommon hematologic malignancy with poor outcomes. Existing data on the clinical behavior of BPDCN…”
Get full text

Utilizing a PLASMIC score‐based approach in the management of suspected immune thrombotic thrombocytopenic purpura: a cost minimization analysis within the Harvard TMA Research Collaborative by Upadhyay, Vivek A., Geisler, Benjamin P., Sun, Lova, Uhl, Lynne, Kaufman, Richard M., Stowell, Christopher, Makar, Robert S., Bendapudi, Pavan K.

“…Summary The PLASMIC score is a recently described clinical scoring algorithm that rapidly assesses the probability of severe ADAMTS13 (a disintegrin and…”
Get full text

Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura by Sun, Lova, Mack, Johnathan, Li, Ang, Ryu, Justine, Upadhyay, Vivek A., Uhl, Lynne, Kaufman, Richard M., Stowell, Christopher P., Dzik, Walter S., Makar, Robert S., Bendapudi, Pavan K.

“…Patients with immune-mediated thrombotic thrombocytopenic purpura (iTTP) often experience life-threatening relapses of the disease, and rituximab (RTX) can be…”
Get full text

Isocitrate dehydrogenase (IDH) inhibition as treatment of myeloid malignancies: Progress and future directions by Upadhyay, Vivek A, Brunner, Andrew M, Fathi, Amir T

“…Isocitrate dehydrogenase (IDH) is an essential metabolic enzyme. Over the last two decades, there has been a growing focus on the metabolic derangements that…”
Get full text

Induction chemotherapy in acute myeloid leukaemia: origins and emerging directions by Upadhyay, Vivek A, Fathi, Amir T

“…PURPOSE OF REVIEWThis review summarizes the hallmark developments in induction chemotherapy for acute myeloid leukaemia and further describes future directions…”
Get full text

Real-World Analysis of Off-Label Use of Molecularly Targeted Therapy in a Large Academic Medical Center Cohort by Upadhyay, Vivek A, Johnson, Bruce E, Landman, Adam B, Hassett, Michael J

“…The primary objective of this study is to quantify the use of off-label molecularly targeted therapy and describe the clinical situations in which off-label…”
Get more information

Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma by Murugesan, Karthikeyan, Sharaf, Radwa, Montesion, Meagan, Moore, Jay A, Pao, James, Pavlick, Dean C, Frampton, Garrett M, Upadhyay, Vivek A, Alexander, Brian M, Miller, Vincent A, Javle, Milind M, Bekaii Saab, Tanios S, Albacker, Lee A, Ross, Jeffrey S, Ali, Siraj M

“…Combined hepatocellular cholangiocarcinoma (cHCC-CCA) is a rare, aggressive primary liver carcinoma, with morphologic features of both hepatocellular…”
Get more information

The Approach to Acute Lymphoblastic Leukemia in Older Patients: Conventional Treatments and Emerging Therapies by Fedorov, Victor D., Upadhyay, Vivek A., Fathi, Amir T.

“…Acute lymphoblastic leukemia (ALL) among older adult patients presents significant clinical challenges. As opposed to pediatric populations, in whom long-term…”
Get full text

Predictors of Relapse and Efficacy of Rituximab in Autoimmune Thrombotic Thrombocytopenic Purpura (TTP): A Multi-Institutional Registry-Based Analysis by Sun, Lova, Mack, Johnathan P., Li, Ang, Ryu, Justine, Upadhyay, Vivek A, Makar, Robert, Bendapudi, Pavan

“…Introduction: Thrombotic thrombocytopenic purpura (TTP) is a distinct and lethal subtype of thrombotic microangiopathy (TMA) requiring treatment with…”
Get full text

Projected Cost Savings of a Plasmic Score-Based Approach to Patients with Suspected Thrombotic Thrombocytopenic Purpura by Upadhyay, Vivek A, Geisler, Benjamin, Sun, Lova, Stowell, Christopher P., Uhl, Lynne, Kaufman, Richard, Makar, Robert, Bendapudi, Pavan

“…Background: Thrombotic thrombocytopenic purpura (TTP) is a rare but deadly thrombotic microangiopathy (TMA) that is caused by a severe acquired deficiency in…”
Get full text